======= PUS7 ======= == Gene Information == * **Official Symbol**: PUS7 * **Official Name**: pseudouridine synthase 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54517|54517]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96PZ0|Q96PZ0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PUS7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PUS7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616261|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |TruD| |mRNA pseudouridine synthesis| |tRNA pseudouridine synthesis| |pseudouridine synthase activity| |regulation of mesoderm development| |pseudouridine synthesis| |mRNA modification| |regulation of hematopoietic stem cell differentiation| |regulation of hematopoietic progenitor cell differentiation| |tRNA modification| |regulation of stem cell differentiation| |negative regulation of translation| |tRNA processing| |negative regulation of cellular amide metabolic process| |RNA modification| |tRNA metabolic process| |enzyme binding| |regulation of translation| |ncRNA processing| |regulation of cellular amide metabolic process| |regulation of hemopoiesis| |ncRNA metabolic process| |posttranscriptional regulation of gene expression| |mRNA metabolic process| |RNA processing| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |regulation of immune system process| |RNA metabolic process| |negative regulation of gene expression| |regulation of cell differentiation| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp100|NFN1 1μM R03 exp100]]|-2.76| |[[:results:exp99|NFN1 0.4μM R03 exp99]]|-2.61| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-2.58| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.4| |[[:results:exp360|Genistein 15μM R07 exp360]]|-2.21| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.17| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.14| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.06| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-2.01| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.98| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-1.83| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|-1.78| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.04| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15027 * **Expression level (log2 read counts)**: 6.08 {{:chemogenomics:nalm6 dist.png?nolink |}}